Wells Fargo Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $50

Benzinga · 1d ago
Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $55 to $50.